Product Code: GVR-4-68040-082-7
U.S. Orthopedic Spine Navigation Systems Market Growth & Trends
The U.S. orthopedic spine navigation systems market size is expected to reach USD 459.8 million by 2030, registering a CAGR of 12.4% over the forecast period, based on a new report by Grand View Research, Inc. The market is expected to continue growing in the coming years, driven by technological advancements, increasing demand for minimally invasive spinal procedures, increasing geriatric population, and the increasing prevalence of spinal disorders. Spine navigation systems play an important role in Minimally Invasive Surgery (MIS) procedures by allowing surgeons to precisely guide instruments and implants in real-time, reducing the need for extensive tissue dissection and minimizing the risk of complications. Furthermore, the regional market is highly competitive with the presence of major players, such as Johnson & Johnson (DePuy Synthes), Stryker, and Zimmer Biomet.
In November 2020, Stryker completed the acquisition of Wright Medical Group N.V., which would expand its product offerings. The spine navigation market was negatively impacted by the COVID-19 pandemic, particularly in the first half of 2020 when many elective surgeries were postponed or canceled due to healthcare facility closures, patient fears, and supply chain disruptions. According to a new study published in the Annals of Surgery in 2020, the cost of halting major elective surgery due to COVID-19 is projected to be USD 22.3 billion for hospitals in the U.S., thereby hampering the market growth. However, the market has started to recover since then, as healthcare systems have adapted to the new normal, and elective procedures have resumed.
U.S. Orthopedic Spine Navigation Systems Market Report Highlights
- The optical technology segment held the largest revenue share of 40.1% in 2022. This is owing to the increased volume of MIS procedures and high adoption of digital surgery solutions by end-users
- The other segment, which comprises hybrid, CT-based, and fluoroscopy-based navigation systems, is expected to witness the fastest CAGR of 12.1% during the forecast period
- The hospitals end-use segment accounted for the largest share of 73.9% in 2022. This can be attributed to a rise in preference for MIS procedures and the fact that many orthopedic surgeries are performed in hospital settings
- On the other hand, the Ambulatory Surgical Centers (ASCs) segment is projected to register the fastest growth rate of 12.5% during the forecast period
Table of Contents
Chapter 1 Methodology And Scope
- 1.1 Market Segmentation And Scope
- 1.2 Research Methodology
- 1.3 Information Procurement
- 1.3.1 Purchased Database:
- 1.3.2 Gvr's Internal Database
- 1.3.3 Secondary Sources
- 1.3.4 Primary Research
- 1.3.5 Details Of Primary Research
- 1.4 Information Or Data Analysis
- 1.4.1 Data Analysis Models
- 1.5 Market Formulation & Validation
- 1.6 Model Details
- 1.6.1 Commodity Flow Analysis (Model 1)
- 1.6.2. Approach 1: Commodity Flow Approach
- 1.6.3 Volume Price Analysis (Model 2)
- 1.6.3.1 Approach 2: Volume Price Analysis
- 1.7 List Of Secondary Sources
- 1.8 List Of Primary Sources
- 1.9 List Of Abbreviations
- 1.10 Objectives
- 1.10.1 Objective 1
- 1.10.2 Objective 2
- 1.10.3 Objective 3
- 1.10.4 Objective 4
Chapter 2 Executive Summary
- 2.1 Market Outlook
- 2.2 Segment Outlook
- 2.3 Competitive Insights
Chapter 3 U.S. Orthopedic Spine Navigation Systems Market Variables, Trends & Scope
- 3.1 Market Lineage Outlook
- 3.1.1 Parent Market Outlook
- 3.1.2 Ancillary Market Outlook
- 3.2 Penetration & Growth Prospect Mapping
- 3.3 User Perspective Analysis
- 3.3.1 Consumer Behavior Analysis
- 3.3.2 Market Influencer Analysis
- 3.4 List Of Key End-Users
- 3.5 Market Dynamics
- 3.5.1 Market Driver Analysis
- 3.5.1.1 Increase In The Prevalence of Spinal Disorders
- 3.5.1.2 Rising number of sports & road injuries
- 3.5.2 Market Restraints Analysis
- 3.5.2.1 High Cost of Spinal Procedures
- 3.5.2.2 Regulatory Barriers
- 3.5.3 Market Opportunity Analysis
- 3.5.3.1 Rising Number Of Government Initiatives
- 3.5.3.2 Improvements In Public And Private Hospital Infrastructure
- 3.6 U.S Orthopedic Spine Navigation Systems: Market Analysis Tools
- 3.6.1 Industry Analysis - Porter's
- 3.6.2 Swot Analysis, By Pest
- 3.7 Impact Of Covid-19 On Market & Post Pandemic Insights
Chapter 4 U.S Orthopedic Spine Navigation Systems Market: Segment Analysis, By Technology, 2017 - 2030 (USD Million)
- 4.1 Definition And Scope
- 4.2 Technology Market Share Analysis, 2022 & 2030
- 4.3 Segment Dashboard
- 4.4 U.S Orthopedic Spine Navigation Systems Market, By Technology, 2017 To 2030
- 4.5 Market Size & Forecasts And Trend Analyses, 2017 To 2030
- 4.5.1 Optical
- 4.5.1.1 Optical Market, 2017 - 2030 (USD Million)
- 4.5.2 Electromagnetic
- 4.5.2.1 Electromagnetic Market, 2017 - 2030 (USD Million)
- 4.5.3 Others
- 4.5.2.1 Others Market, 2017 - 2030 (USD Million)
Chapter 6 U.S Orthopedic Spine Navigation Systems Market: Segment Analysis, By End-Use, 2017 - 2030 (USD Million)
- 6.1 Definition And Scope
- 6.2 End-Use Market Share Analysis, 2022 & 2030
- 6.3 Segment Dashboard
- 6.4 U.S Orthopedic Spine Navigation Systems Market, By End-Use, 2017 To 2030
- 6.5 Market Size & Forecasts And Trend Analyses, 2017 To 2030
- 6.5.1 Hospitals
- 6.5.1.1 Hospitals Market, 2017 - 2030 (USD Million)
- 6.5.2 Ambulatory Surgical Centers
- 6.5.2.1 Therapeutic Injections Market, 2017 - 2030 (USD Million)
Chapter 7 U.S Orthopedic Spine Navigation Systems Market - Competitive Analysis
- 7.1 Recent Developments & Impact Analysis, By Key Market Participants
- 7.2 Company Categorization
- 7.2.1 Innovators
- 7.2.2 Market Leaders
- 7.3 Vendor Landscape
- 7.3.1 Key Company Position Analysis, 2022
- 7.3.2 Major Deals And Strategic Alliances
- 7.3.2.1 New Product Launch
- 7.3.2.2 Expansion
- 7.3.2.3 Acquisition
- 7.3.3 Market Entry Strategies
- 7.4 Company Profiles
- 7.4.1 B. Braun Melsungen AG
- 7.4.1.1 Company Overview
- 7.4.1.2 Financial Performance
- 7.4.1.3 Product Benchmarking
- 7.4.1.4 Strategic Initiatives
- 7.4.2 Stryker
- 7.4.2.1 Company Overview
- 7.4.2.2 Financial Performance
- 7.4.2.3 Product Benchmarking
- 7.4.2.4 Strategic Initiatives
- 7.4.3 Medtronic
- 7.4.3.1 Company Overview
- 7.4.3.2 Financial Performance
- 7.4.3.3 Product Benchmarking
- 7.4.3.4 Strategic Initiatives
- 7.4.4 Smith Nephew
- 7.4.4.1 Company Overview
- 7.4.4.2 Financial Performance
- 7.4.4.3 Product Benchmarking
- 7.4.4.4 Strategic Initiatives
- 7.4.5 Johnson & Johnson Services, Inc. (DePuy Synthes)
- 7.4.5.1 Company Overview
- 7.4.5.2 Financial Performance
- 7.4.5.3 Product Benchmarking
- 7.4.5.4 Strategic Initiatives
- 7.4.6 Zimmer Biomet
- 7.4.6.1 Company Overview
- 7.4.6.2 Financial Performance
- 7.4.6.3 Product Benchmarking
- 7.4.6.4 Strategic Initiatives
- 7.4.7 Kinamed, Inc.
- 7.4.7.1 Company Overview
- 7.4.7.2 Financial Performance
- 7.4.7.3 Product Benchmarking
- 7.4.7.4 Strategic Initiatives
- 7.4.8 Globus Medical
- 7.4.8.1 Company Overview
- 7.4.8.2 Financial Performance
- 7.4.8.3 Product Benchmarking
- 7.4.8.4 Strategic Initiatives
- 7.4.9 OrthAlign
- 7.4.9.1 Company Overview
- 7.4.9.2 Financial Performance
- 7.4.9.3 Product Benchmarking
- 7.4.9.4 Strategic Initiatives
- 7.4.10 Novarad Corporation
- 7.4.10.1 Company Overview
- 7.4.10.2 Financial Performance
- 7.4.10.3 Product Benchmarking
- 7.4.10.4 Strategic